|
Biography of Jouko HaapalahtiPresident and CEO at JouZeNet Consulting Ltd 2012-
Senior Business Consultant and Advisor in Life Sciences & Diagnostics |
|
- Honorary Doctor of Medicine (MD., PhD(hc.)), Executive Master of Business Administration (eMBA), Bachelor of Science in Clinical Biochemistry (B.Sc), University of Oulu, Finland
- Clinical biochemist at the Hospital Laboratory of the Deaconess Institute, Oulu, 1970–1978
- Co-founder and Managing Director of a diagnostic company Nordiclab Ltd, Oulu, 1976–1982
- Director of the diagnostics plant of Farmos Diagnostica, Oulunsalo, 1982–1992
- Assistant Vice President of Orion Diagnostica Ltd, 1992–2012; several responsibilities, e.g. for R&D, new business development and partnerships with academia and bioindustries (Finland, USA, Germany, France, Japan)
- Program Director and Chief Financial Officer of the SalWe Intelligent Monitoring of Health and Well-being Program (€25M), 2010–2014; and CFO of the Mind and Body Program (€36M), 2012–2014
- Successful transfers of IP and technology on R2B or B2B basis; 10 licensing agreements signed in 2016-2018
- Several consultations to the investors regarding in vitro diagnostics; 6 IVD-market overviews given in 2017-2018
- Board member of Faculty of Biochemistry and Molecular Medicine, University of Oulu, 2018-
- Co-author of 25 scientific publications related to biochemical endocrinology and bone metabolism
- Co-inventor of a patent family related to the biochemical diagnostics of heart failure
- Co-author of a chapter in the book “Hormonal Therapies in Postmenopausal Osteoporosis” and author of an article in the book “Advances in Developing Affordable In Vitro Molecular Diagnostics”
- EU FP7, member of working group for “Detection, Diagnostics and Monitoring”, 2005
- Co-founder and chairman of the Finnish In Vitro Diagnostics Industry Cluster 1997-2017
- Chair of BioCluster Oulu, 2001–2006; Chair of the Advisory Board of BioForum, 2006–2013, board member of Finnish Bioindustries FIB 2006-2013, Chair or member of the steering committee of several BusinessFinland research and FiDiPro programs, the IVD Graduate School, the Finnish nanotechnology cluster, and the “Bio Meets Nano and IT”